Lu AA24493 (CEPO)

DRUG2 trials

Sponsors

H. Lundbeck A/S

Conditions

Acute Ischemic Stroke

Phase 1

Safety Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke

CompletedNCT00756249

H. Lundbeck A/SAcute Ischemic Stroke

Start: 2007-10-31End: 2008-12-31Updated: 2010-09-27

Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke

CompletedNCT00870844

H. Lundbeck A/SAcute Ischemic Stroke

Start: 2009-05-31End: 2011-03-31Updated: 2011-04-20